Showing results 1 to 20 of 23
next >
| Issue Date | Title | Author(s) |
| 2022-02-01 | The aryl-ureido fatty acid CTU activates endoplasmic reticulum stress and PERK/NOXA-mediated apoptosis in tumor cells by a dual mitochondrial-targeting mechanism. | Choucair, H; Rahman, MK; Umashankar, B; Al-Zubaidi, Y; Bourget, K; Chen, Y; Dunstan, C; Rawling, T; Murray, M |
| 2021-10 | PTU, a novel ureido-fatty acid, inhibits MDA-MB-231 cell invasion and dissemination by modulating Wnt5a secretion and cytoskeletal signaling. | Al-Zubaidi, Y; Chen, Y; Khalilur Rahman, M; Umashankar, B; Choucair, H; Bourget, K; Chung, L; Qi, Y; Witting, PK; Anderson, RL; O'Neill, GM; Dunstan, CR; Rawling, T; Murray, M |
| 2021-04-01 | Complex soil contamination severely impacts seed-sown crop viability in Australia | McDonald, A; Murray, B; Krix, D; Murray, M |
| 2021-02-16 | Chapter 3 Sustainable origin-sorbents for heavy metal contamination: Research progress within an Australian context | Murray, M; Bugdayli, K |
| 2020 | Omega-3 Polyunsaturated Fatty Acid Derived Lipid Mediators and Their Application in Drug Discovery. | Pazderka, CW; Oliver, B; Murray, M; Rawling, T |
| 2019-11-01 | Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib | Murray, M; Gillani, TB; Rawling, T; Nair, PC |
| 2019-03-01 | Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cells | Al-Zubaidi, Y; Pazderka, C; Koolaji, N; Rahman, MK; Choucair, H; Umashankar, B; Bourget, K; Chen, Y; Rawling, T; Murray, M |
| 2019-03-01 | Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4 | Ghassabian, S; Gillani, TB; Rawling, T; Crettol, S; Nair, PC; Murray, M |
| 2018-10-13 | Nanoemulsion-enabled oral delivery of novel anticancer ω-3 fatty acid derivatives | Pereira, GG; Rawling, T; Pozzoli, M; Pazderka, C; Chen, Y; Dunstan, CR; Murray, M; Sonvico, F |
| 2018-05-23 | Carboxylate Analogues of Aryl-Urea-Substituted Fatty Acids That Target the Mitochondria in MDA-MB-231 Breast Cancer Cells to Promote Cell Death | Koolaji, N; Rawling, T; Bourget, K; Murray, M |
| 2018-03-01 | Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver | Murray, M; Gillani, TB; Ghassabian, S; Edwards, RJ; Rawling, T |
| 2017-10-26 | A Novel Arylurea Fatty Acid That Targets the Mitochondrion and Depletes Cardiolipin to Promote Killing of Breast Cancer Cells | Rawling, T; Choucair, H; Koolaji, N; Bourget, K; Allison, SE; Chen, YJ; Dunstan, CR; Murray, M |
| 2017-01-01 | A novel synthetic analogue of v-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ ASK1/JNK signaling to promote apoptosis in human breast cancer cells | Dyari, HRE; Rawling, T; Chen, Y; Sudarmana, W; Bourget, K; Dwyer, JM; Allison, SE; Murray, M |
| 2015-06-01 | Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs | Murray, M; Hraiki, A; Bebawy, M; Pazderka, C; Rawling, T |
| 2014-11-01 | Selective inhibition of human solute carrier transporters by multikinase inhibitors | Johnston, RA; Rawling, T; Chan, T; Zhou, F; Murray, M |
| 2013-01-01 | Anti-proliferative actions of N0-desmethylsorafenib in human breast cancer cells | Cui, PH; Rawling, T; Gillani, TB; Bourget, K; Wang, XS; Zhou, F; Murray, M |
| 2012-08-23 | Antiproliferative and antimigratory actions of synthetic long chain n-3 monounsaturated fatty acids in breast cancer cells that overexpress cyclooxygenase-2 | Cui, PH; Kirsi Bourget, TR; Kim, T; Duke, CC; Doddareddy, MR; Hibbs, DE; Zhou, F; Tattam, BN; Petrovic, N; Murray, M |
| 2012-07-29 | Synthesis of unsymmetrical biaryl ureas from N-carbamoylimidazoles: Kinetics and application | Rawling, T; McDonagh, AM; Tattam, B; Murray, M |
| 2012-07-15 | Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites | Ghassabian, S; Rawling, T; Zhou, F; Doddareddy, MR; Tattam, BN; Hibbs, DE; Edwards, RJ; Cui, PH; Murray, M |
| 2010-02-01 | Facile and stereoselective synthesis of (Z)-15-octadecenoic acid and (Z)-16-nonadecenoic acid: Monounsaturated omega-3 fatty acids | Rawling, T; Duke, CC; Cui, PH; Murray, M |
